STAAR Surgical to Report Second Quarter Results on August 4, 2021

Rhea-AI Summary

STAAR Surgical Company (NASDAQ: STAA) will announce its second-quarter financial results for the period ending July 2, 2021, on August 4, 2021, after market close. Following the announcement, a conference call will take place on the same day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss the results and operational updates. Participants can join the call by dialing 866-209-9722 (domestic) or 825-312-2235 (international). A replay of the call will be available for a week, along with an archived webcast on www.staar.com.

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the second quarter ended July 2, 2021 on Wednesday, August 4, 2021 after the market close.

STAAR will host a conference call and webcast on Wednesday, August 4 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operational progress. To access the conference call (Conference ID 6090849), please dial 866-209-9722 for domestic participants and 825-312-2235 for international participants. The live webcast can be accessed from the investor relations section of the STAAR website at www.staar.com.

A taped replay of the conference call (Conference ID 6090849) will be available beginning approximately one hour after the call’s conclusion for seven days. This replay can be accessed by dialing 800-585-8367 for domestic callers and 416-621-4642 for international callers. An archived webcast will also be available at www.staar.com.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL”, which includes the EVO Visian ICL™ product line. More than 1,000,000 Visian® ICLs have been implanted to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: www.discovericl.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more information, please visit the Company’s website at www.staar.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20210721005611/en/

FAQ

When will STAAR Surgical release its financial results for Q2 2021?

STAAR Surgical will release its Q2 2021 financial results on August 4, 2021, after market close.

What time is the conference call for STAAR Surgical's Q2 results?

The conference call is scheduled for August 4, 2021, at 4:30 p.m. Eastern / 1:30 p.m. Pacific.

How can I access the STAAR Surgical conference call?

To access the conference call, dial 866-209-9722 for domestic participants or 825-312-2235 for international participants.

Where can I find the archived webcast of the STAAR Surgical call?

The archived webcast of the STAAR Surgical call will be available on their investor relations website, www.staar.com.

How long will the STAAR Surgical conference call replay be available?

The replay of the STAAR Surgical conference call will be available for seven days after the call.